Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Asset Utilization Ratio (2016 - 2025)

Tg Therapeutics has reported Asset Utilization Ratio over the past 10 years, most recently at 0.59 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.59 for Q4 2025, up 4.38% from a year ago — trailing twelve months through Dec 2025 was 0.59 (up 4.38% YoY), and the annual figure for FY2025 was 0.75, up 3.57%.
  • Asset Utilization Ratio for Q4 2025 was 0.59 at Tg Therapeutics, down from 0.62 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for TGTX hit a ceiling of 0.9 in Q2 2024 and a floor of 0.0 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.33 (2023), compared with a mean of 0.35.
  • Biggest five-year swings in Asset Utilization Ratio: soared 5127.3% in 2023 and later dropped 25.38% in 2025.
  • Tg Therapeutics' Asset Utilization Ratio stood at 0.02 in 2021, then fell by 20.16% to 0.01 in 2022, then soared by 5127.3% to 0.71 in 2023, then fell by 20.06% to 0.57 in 2024, then grew by 4.38% to 0.59 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.59 (Q4 2025), 0.62 (Q3 2025), and 0.67 (Q2 2025) per Business Quant data.